VCM
ITCI
Versant Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-197
| Closed | -$26K | – | 2760 |
|
|
2025
Q1 | $26K | Buy |
197
+61
| +45% | +$8.05K | ﹤0.01% | 1198 |
|
|
2024
Q4 | $11.4K | Buy |
136
+27
| +25% | +$2.26K | ﹤0.01% | 1329 |
|
|
2024
Q3 | $7.98K | Hold |
109
| – | – | ﹤0.01% | 1132 |
|
|
2024
Q2 | $7.47K | Buy |
109
+89
| +445% | +$6.1K | ﹤0.01% | 1090 |
|
|
2024
Q1 | $1.38K | Hold |
20
| – | – | ﹤0.01% | 1459 |
|
|
2023
Q4 | $1.43K | Buy |
20
+6
| +43% | +$430 | ﹤0.01% | 1404 |
|
|
2023
Q3 | $729 | Sell |
14
-9
| -39% | -$469 | ﹤0.01% | 1618 |
|
|
2023
Q2 | $1.46K | Buy |
23
+9
| +64% | +$570 | ﹤0.01% | 1492 |
|
|
2023
Q1 | $758 | Hold |
14
| – | – | ﹤0.01% | 1511 |
|
|
2022
Q4 | $741 | Hold |
14
| – | – | ﹤0.01% | 1369 |
|
|
2022
Q3 | $1K | Hold |
14
| – | – | ﹤0.01% | 1382 |
|
|
2022
Q2 | $1K | Hold |
14
| – | – | ﹤0.01% | 1389 |
|
|
2022
Q1 | $1K | Hold |
14
| – | – | ﹤0.01% | 1408 |
|
|
2021
Q4 | $1K | Hold |
14
| – | – | ﹤0.01% | 1383 |
|
|
2021
Q3 | $1K | Hold |
14
| – | – | ﹤0.01% | 1399 |
|
|
2021
Q2 | $1K | Hold |
14
| – | – | ﹤0.01% | 1394 |
|
|
2021
Q1 | $0 | Hold |
14
| – | – | ﹤0.01% | 1625 |
|
|
2020
Q4 | $0 | Hold |
14
| – | – | ﹤0.01% | 1567 |
|
|
2020
Q3 | $0 | Hold |
14
| – | – | ﹤0.01% | 1547 |
|
|
2020
Q2 | $0 | Hold |
14
| – | – | ﹤0.01% | 1607 |
|
|
2020
Q1 | $0 | Buy |
+14
| New | – | ﹤0.01% | 1750 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 1599 |
|
|
2017
Q2 | – | Sell |
-19
| Closed | – | – | 1566 |
|
|
2017
Q1 | $0 | Buy |
+19
| New | – | ﹤0.01% | 1565 |
|